Neurotensin receptor activation sensitizes to the locomotor stimulant effect of cocaine: A role for NMDA receptors

Brain Research

Volumn 1085, Issue 1, 2006, Pages 77-86

  Rompré, Pierre Paul ^a   Bauco, Pat ^a  

^a CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

Author keywords

Cocaine; Glutamate; Locomotion; Neurotensin; Sensitization

Indexed keywords

3 (2 CARBOXYPIPERAZINE 4 YL) PROPANEPHOSPHONIC ACID; COCAINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTENSIN RECEPTOR; NEUROTENSIN[11 DEXTRO TRYPTOPHAN]; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG INHIBITION; HISTOLOGY; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SENSITIZATION; STATISTICAL ANALYSIS;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; COCAINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MOTOR ACTIVITY; NEUROTENSIN; PIPERAZINES; RATS; RATS, LONG-EVANS; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, NEUROTENSIN; TIME FACTORS;

ANIMALIA;

EID: 33646564017     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.02.011     Document Type: Article

References (57)

1. Beauregard M., Ferron A., and Descarries L. Opposite effects of neurotensin on dopamine inhibition in different regions of the rat brain: an iontophoretic study. Neuroscience 47 (1992) 613-619
2. Binder E.B., Kinkead B., Owens M.J., and Nemeroff C.B. Neurotensin and dopamine interactions. Pharmacol. Rev. 53 (2001) 453-486
3. Bjijou Y., Stinus L., Le Moal M., and Cador M. Evidence for selective involvement of dopamine D1 receptors of the ventral tegmental area in the behavioral sensitization induced by intra-ventral tegmental area injections of d-amphetamine. J. Pharmacol. Exp. Ther. 277 (1996) 1177-1187
4. Blackburn A., Dewar K.M., Bauco P., and Rompré P.-P. Excitotoxic lesions of the prefrontal cortex attenuate the potentiation of amphetamine-induced locomotion by repeated neurotensin receptor activation. Brain Res. 998 (2004) 184-193
5. Blaha C.D., and Phillips A.G. Pharmacological evidence for common mechanisms underlying the effects of neurotensin and neuroleptics on in vivo dopamine efflux in the rat nucleus accumbens. Neuroscience 49 (1992) 867-877
6. Boudin H., Pelaprat D., Rostene W., and Beaudet A. Cellular distribution of neurotensin receptors in rat brain: immunohistochemical study using an antipeptide antibody against the cloned high affinity receptor. J. Comp. Neurol. 373 (1996) 76-89
7. Cador M., Bjijou Y., Cailhol S., and Stinus L. d-Amphetamine-induced behavioral sensitization: implication of a glutamatergic medial prefrontal cortex-ventral tegmental area innervation. Neuroscience 94 (1999) 705-721
8. Cornish J.L., and Kalivas P.W. Repeated cocaine administration into the rat ventral tegmental area produces behavioral sensitization to a systemic cocaine challenge. Behav. Brain Res. 126 (2001) 205-209
9. Costa F.G., Frussa R., and Felicio L.F. The neurotensin receptor antagonist, SR48692, attenuates the expression of amphetamine-induced behavioural sensitisation in mice. Eur. J. Pharmacol. 428 (2001) 97-103
10. Doherty M.D., and Gratton A. NMDA receptors in nucleus accumbens modulate stress-induced dopamine release in nucleus accumbens and ventral tegmental area. Synapse 26 (1997) 225-234
11. Elmer G.I., Brockington A., Gorelick D.A., Carrol F.I., Rice K.C., Matecka D., Goldberg S.R., and Rothman R.B. Cocaine cross-sensitization to dopamine uptake inhibitors: unique effects of GBR12909. Pharmacol. Biochem. Behav. 53 (1996) 911-918
12. Ervin G.N., Birkemo L.S., Nemeroff C.B., and Prange A.J. Neurotensin blocks certain amphetamine-induced behaviours. Nature 291 (1981) 73-76
13. Fatigati M.D., Anderson R.M., and Rompre P.P. Effects of prefrontal cortex microinjection of neurotensin-(8-13) on midbrain dopamine and non-dopamine cell firing. Brain Res. 876 (2000) 196-200
14. Feenstra M.G., Botterblom M.H., and van Uum J.F. Behavioral arousal and increased dopamine efflux after blockade of NMDA-receptors in the prefrontal cortex are dependent on activation of glutamatergic neurotransmission. Neuropharmacology 42 (2002) 752-763
15. Ferraro L., Tanganelli S., O'Connor W.T., Bianchi C., Ungerstedt U., and Fuxe K. Neurotensin increases endogenous glutamate release in the neostriatum of the awake rat. Synapse 20 (1995) 362-364
16. Ferraro L., Tomasini M.C., Siniscalchi A., Fuxe K., Tanganelli S., and Antonelli T. Neurotensin increases endogenous glutamate release in rat cortical slices. Life Sci. 66 (2000) 927-936
17. Ferraro L., Tomasini M.C., Fernandez M., Bebe B.W., OConnor W.T., Fuxe K., Glennon J.C., Tanganelli S., and Antonelli T. Nigral neurotensin receptor regulation of nigral glutamate and nigroventral thalamic GABA transmission: a dual-probe microdialysis study in intact conscious rat brain. Neuroscience 102 (2001) 113-120
18. Flores C., and Stewart J. Basic fibroblast growth factor as a mediator of the effects of glutamate in the development of long-lasting sensitization to stimulant drugs: studies in the rat. Psychopharmacology (Berlin) 151 (2000) 152-165
19. Hooks M.S., Jones G.H., Hemby S.E., and Justice J.B. Environmental and pharmacological sensitization: effects of repeated administration of systemic or intra-nucleus accumbens cocaine. Psychopharmacology 111 (1993) 109-116
20. Horger B.A., Taylor J.R., Elsworth J.D., and Roth R.H. Preexposure to, but not cotreatment with, the neurotensin antagonist SR 48692 delays the development of cocaine sensitization. Neuropsychopharmacology 11 (1994) 215-222
21. Imperato A., Scrocco M.G., Bacchi S., and Angelucci L. NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus. Eur. J. Pharmacol. 187 (1990) 555-556
22. Jolicoeur F.B., Rioux F., Quirion R., and St-Pierre S. Differential neurobehavioral effects of neurotensin and structural analogues. Peptides 2 (1981) 171-175
23. Kalivas P.W. Interactions between dopamine and excitatory amino acids in behavioral sensitization to psychostimulants. Drug Alcohol Depend. 37 (1995) 95-100
24. Kalivas P.W., and Alesdatter J.E. Involvement of N-methyl-d-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 267 (1993) 486-495
25. Kalivas P.W., and Duffy P. Effect of acute and daily neurotensin and enkephalin treatments on extracellular dopamine in the nucleus accumbens. J. Neurosci. 10 (1990) 2940-2949
26. Kalivas P.W., and Duffy P. D1 receptors modulate glutamate transmission in the ventral tegmental area. J. Neurosci. 15 (1995) 5379-5388
27. Kalivas P.W., and Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16 (1991) 223-244
28. Kalivas P.W., and Taylor S. Behavioral and neurochemical effect of daily injection with neurotensin into the ventral tegmental area. Brain Res. 358 (1985) 70-76
29. Kalivas P.W., and Weber B. Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine. J. Pharmacol. Exp. Ther. 245 (1988) 1095-1102
30. Kalivas P.W., Nemeroff C.B., and Prange A.J. Neuroanatomical site specific modulation of spontaneous motor activity by neurotensin. Eur. J. Pharmacol. 78 (1982) 471-474
31. Kalivas P.W., Burgess S.K., Nemeroff C.B., and Prange A.J. Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat. Neuroscience 8 (1983) 495-505
32. Kalivas P.W., Sorg B.A., and Hooks M.S. The pharmacology and neural circuitry of sensitization to psychostimulants. Behav. Pharmacol. 4 (1993) 315-334
33. Leonetti M., Brun P., Clerget M., Steinberg R., Soubrie P., Renaud B., and Suaud-Chagny M.F. Specific involvement of neurotensin type 1 receptor in the neurotensin-mediated in vivo dopamine efflux using knock-out mice. J. Neurochem. 89 (2004) 1-6
34. Li Y., Hu X.T., Berney T.G., Vartanian A.J., Stine C.D., Wolf M.E., and White F.J. Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations. Synapse 34 (1999) 169-180
35. Lopak V., and Erb S. Activation of central neurotensin receptors reinstates cocaine seeking in the rat: modulation by a D1/D5, but not D2/D3, receptor antagonist. Psychopharmacology (Berlin) 182 (2005) 297-304
36. Nemeroff C.B. Neurotensin: perchance an endogenous neuroleptic?. Biol. Psychiatry 15 (1980) 283-302
37. Nicot A., Rostene W., and Berod A. Neurotensin receptor expression in the rat forebrain and midbrain: a combined analysis by in situ hybridization and receptor autoradiography. J. Comp. Neurol. 341 (1994) 407-419
38. Panayi F., Colussi-Mas J., Lambas-Senas L., Renaud B., Scarna H., and Berod A. Endogenous neurotensin in the ventral tegmental area contributes to amphetamine behavioral sensitization. Neuropsychopharmacology 30 (2005) 871-879
39. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1998), Academic Press, San Diego
40. Petrie K.A., Schmidt D., Bubser M., Fadel J., Carraway R.E., and Deutch A.Y. Neurotensin activates GABAergic interneurons in the prefrontal cortex. J. Neurosci. 25 (2005) 1629-1636
41. Radcliffe R.A., and Erwin V.G. Alterations in locomotor activity after microinjections of GBR-12909, selective dopamine antagonists or neurotensin into the medial prefrontal cortex. J. Pharmacol. Exp. Ther. 277 (1996) 1467-1476
42. Radke J.M., Owens M.J., and Nemeroff C.B. The effects of glutamate receptor agonists on neurotensin release using in vivo microdialysis. Eur. J. Pharmacol. 411 (2001) 129-134
43. Robledo P., Maldonado R., and Koob G.F. Neurotensin injected into the nucleus accumbens blocks the psychostimulant effects of cocaine but does not attenuate cocaine self-administration in the rat. Brain Res. 622 (1993) 105-112
44. Rompré P.-P. Repeated activation of neurotensin receptors sensitizes to the stimulant effect of amphetamine. Eur. J. Pharmacol. 328 (1997) 131-134
45. Rompré P.-P., and Perron S. Evidence for a role of endogenous neurotensin in the initiation of amphetamine sensitization. Neuropharmacology 39 (2000) 1880-1892
46. Rompré P.-P., Boye S.M., and Moisan J. Activation of neurotensin receptors in the prefrontal cortex stimulates midbrain dopamine cell firing. Eur. J. Pharmacol. 341 (1998) 169-172
47. Sesack S.R., and Pickel V.M. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J. Comp. Neurol. 320 (1992) 145-160
48. Steketee J.D. Neurotransmitter systems of the medial prefrontal cortex: potential role in sensitization to psychostimulants. Brain Res. Rev. 41 (2003) 203-228
49. Steketee J.D., and Walsh T.J. Repeated injections of sulpiride into the medial prefrontal cortex induces sensitization to cocaine in rats. Psychopharmacology (Berlin) 179 (2005) 753-760
50. Suto N., Tanabe L.M., Austin J.D., Creekmore E., and Vezina P. Previous exposure to VTA amphetamine enhances cocaine self-administration under a progressive ratio schedule in an NMDA, AMPA/kainate, and metabotropic glutamate receptor-dependent manner. Neuropsychopharmacology 28 (2003) 629-639
51. Takahata R., and Moghaddam B. Glutamatergic regulation of basal and stimulus-activated dopamine release in the prefrontal cortex. J. Neurochem. 71 (1998) 1443-1449
52. Tzschentke T.M., and Schmidt W.J. The development of cocaine-induced behavioral sensitization is affected by discrete quinolinic acid lesions of the prelimbic medial prefrontal cortex. Brain Res. 795 (1998) 71-76
53. Vanderschuren L.J., and Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berlin) 151 (2000) 99-120
54. White F.J., and Kalivas P.W. Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend. 51 (1998) 141-153
55. Wise R.A., and Leeb K. Psychomotor-stimulant sensitization: a unitary phenomenon?. Behav. Pharmacol. 4 (1993) 339-1349
56. Wolf M.E., and Xue C.J. Amphetamine and D1 dopamine receptor agonists produce biphasic effects on glutamate efflux in rat ventral tegmental area: modification by repeated amphetamine administration. J. Neurochem. 70 (1998) 198-209
57. Wolf M.E., Dahlin S.L., Hu X.-T., Xue C.-J., and White K. Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: comparison with N-methyl-d-aspartate antagonists. Neuroscience 69 (1995) 417-439